Transcription factors belonging to the Per/Arnt/Sim (PAS) domain family are highly conserved and many are involved in circadian rhythm regulation. One member of this family, aryl hydrocarbon receptor (AhR), is an orphan receptor whose physiological role is unknown. Recent findings have led to the hypothesis that AhR has a role in circadian rhythm, which is the focus of the present investigation. First, time-of-day-dependent mRNA expression of AhR and its signaling target, cytochrome p4501A1 (Cyp1a1), was determined in C57BL/6J mice by quantitative RT-PCR. Circadian expression of AhR and Cyp1a1 was observed both in the suprachiasmatic nucleus (SCN) and liver. Next, the circadian phenotype of mice lacking AhR (AhRKO) was investigated using behavioral monitoring. Intact AhRKO mice had robust circadian rhythmicity with a similar tau under constant conditions compared to wild-type mice, but a significant difference in tau was observed between genotypes in ovariectomized female mice. Time to reentrainment following 6-h advances or delays of the light/dark cycle was not significantly different between genotypes. However, mice exposed to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 1 μg/kg of body weight) displayed decreased phase shifts in response to light and had altered expression of Per1 and Bmal1. These results suggest that chronic activation of AhR may affect the ability of the circadian timekeeping system to adjust to alterations in environmental lighting by affecting canonical clock genes. Further studies are necessary to decipher the mechanism of how AhR agonists could disrupt light-induced phase shifts. If AhR does have a role in circadian rhythm, it may share redundant roles with other PAS domain proteins and/or the role of AhR may not be exhibited in the behavioral activity rhythm, but could be important elsewhere in the peripheral circadian system.
Many proteins involved in the clockwork mechanism, including CLOCK (circadian locomotor output cycles kaput), BMAL1 (brain and muscle, ARNT-like), and NPAS2 (neuronal PAS protein 2), belong to the basic helix-loop-helix/Per-ARNT-SIM (bHLH/PAS) domain family. Another bHLH/PAS domain protein, aryl hydrocarbon receptor (AhR), has been extensively studied for its role in mediating the toxicity of environmental contaminants, such as the halogenated aromatic hydrocarbons. Among them is the prototypical dioxin, 2, 3, 7, dioxin) .
TCDD is formed as a by-product of combustion processes during chlorine bleaching of paper products and in the production of pesticides and herbicides. Human and animal exposure occurs at low levels primarily through the consumption of contaminated food such as fish, meat, and dairy products (Travis and Hattemer-Frey, 1991) . Due to the lipophilicity of TCDD and its slow rate of metabolism, it bioaccumulates in animals and humans and biomagnifies in the environment. It is not readily metabolized in vivo and its halflife can be as long as several to more than 10 years in humans (Aylward et al., 2005) . Toxic effects of TCDD include teratogenesis, immune impairment, carcinogenesis, and developmental and reproductive dysfunction (Birnbaum, 1994; Pohjanvirta and Tuomisto, 1994) .
AhR activation by TCDD leads to nuclear translocation of the TCDD-bound AhR followed by its dimerization with another PAS domain-dependent transcription factor, the aryl hydrocarbon receptor nuclear translocator (ARNT). The AhR:ARNT heterodimer binds to xenobiotic response elements (XREs; also known as dioxin-response elements, DREs) to induce a battery of AhR-responsive genes including those that are involved in xenobiotic metabolism (Nebert et al., 1993) . Endogenous ligands for AhR have been sought for decades (Bjeldanes et al., 1991; McMillan and Bradfield, 2007; Rannug et al., 1995; Song et al., 2002) . However, they remain elusive, and thus, the physiological role of AhR remains unknown.
AhR sequences have been identified in early vertebrates and possible homologs have been suggested even in C. elegans (Hahn et al., 1997) . Mice lacking AhR show abnormal liver development, ductus venosus retention, immune system impairment, and abnormal ovarian follicular development (Benedict et al., 2000; Fernandez-Salguero et al., 1995; Lahvis et al., 2005; Schmidt et al., 1996) . The evolutionary conservation of AhR and abnormal phenotype of AhR null mice strongly suggests the importance of AhR in normal physiological function. Recently, tryptophan photoproducts have been suggested as potential endogenous AhR ligands, and AhR may have a role in the regulation of biological rhythms (Rannug and Fritsche, 2006) . The trypotophan photoproduct 6-formylindolo[3,2-b]carbazole (FICZ) blocks glutamate-induced phase shifts in suprachiasmatic nucleus (SCN) slices (Mukai and Tischkau, 2007) , lending credence to this hypothesis.
Daily rhythms of AhR protein expression have been reported in liver, lung, and thymus (Richardson et al., 1998) . In addition, diurnal expression of AhR mRNA, as well as its downstream target gene, cytochrome P4501A1 (Cyp1a1), occurs in liver and pituitary (Huang et al., 2002) . Thus, AhR-related genes exhibit a circadian rhythm, similar to many other "clock" genes. However, previous studies were done only under light/darkness (LD) conditions. We determined expression patterns of these genes both under LD and constant darkness (DD) conditions to reveal their endogenous rhythms in SCN and liver. We also examined circadian behavior in AhR null (AhRKO) mice. Finally, we tested the effect of TCDD on light regulation of circadian rhythm. Our results demonstrate that AhR and its signaling targets maintain rhythmicity under DD. AhRKO mice overall have robust rhythmicity under LD, DD, and LL (constant light) conditions and adjust well to jetlag-like light entrainment shifts. However, exposure to TCDD attenuates light-induced phase shifts, suggesting interactions between activation of AhR signaling and the circadian system.
MATERIALS AND METHODS

Animals
Unless noted otherwise, 6-week-old wild-type (WT) male C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) were used. For activity measurements in AhRKO, founding breeders on a C57BL/6J background (Schmidt et al., 1996) were bred at the University of Illinois, Urbana-Champaign. Genotypes of pups resulting from AhR +/male/female crosses were determined by PCR (Benedict et al., 2000) . WT siblings were used as controls in these experiments. Animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Illinois and were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals.
Tissue Collection
Male C57BL/6J mice were housed 3 to 4 per cage in a light-tight chamber, provided with feed and water ad libitum, and entrained for at least 2 weeks under controlled lighting (12L:12D), temperature (22°C ), and humidity (39%). Fluorescent light bulbs (13 W; Sylvania, Danvers, MA) generated 400 to 500 lux of light to the cages. All other experiments described herein were done under these environmental conditions. Animals were decapitated; liver and SCN were collected at 4-h intervals starting at ZT0 (zeitgeber time, lights on at ZT0, lights off at ZT12). For DD collection, animals were placed in darkness for 48 h before collection at 4-h intervals. Circadian time (CT) was reckoned from the previous light/dark cycle. SCN were carefully punched from a 500-μm brain slice using a 1-mm-diameter sample corer (Fine Science Tools, Foster City, CA). Tissues were snapfrozen and stored at -80 °C until use.
For investigating clock gene expression in AhRKO and in TCDD-exposed mice, 2 time points, CT8 and CT20, were chosen based on the time when clear out of phase relationship of Per1 and Bmal1 was observed under DD conditions. In this experiment, after 2 weeks of entrainment under LD, the animals were orally dosed with 1 μg/kg of body weight (BW) of TCDD or vehicle (corn oil) during their lights-on period and released into DD 6 days after treatment. Both liver and SCN were collected on the third day in DD.
Real-Time Quantitative PCR
Total RNA was isolated using TRIzol (GIBCO BRL, Gaithersburg, MD) for liver and RNAqueous (Ambion, Austin, TX) for SCN, and qPCR was performed as previously described (Mukai and Tischkau, 2007) . Primers were designed across 2 exons to inhibit amplification of genomic DNA using Primer Express 3 (PE Applied Biosystems, Warrington, UK). Specific primer sequences used were: forward 5′-TTCTTAGGCTCA-GCGTCAGCTA-3′ and reverse 3′-GCAAATCCTGCC-AGTCTCTGAT-3′ for AhR; forward 5′-CTACAAGC-CAACATTTCTATCAGATGA-3′ and reverse 5′-GGT-CACATCCTACGACAAACAAAA-3′ for Bmal1; and as previously published (Mukai and Tischkau, 2007) for Cyp1a1 and Per1. The Ct (threshold cycle) value was obtained, and relative RNA amount was calculated using the relative standard curve method (Applied Biosystems User Bulletin 2). Serial dilutions of pooled RNA, representative of all times of day, were used to generate standard curves. Linear regression analysis produced an equation for determining doubling efficiency and expression of each transcript. Internal standards were not used because many "housekeeping genes" exhibit circadian variation.
Activity Recording
WT and AhRKO mice were housed individually in 30 × 19 × 12.5-cm cages (Ancare, Bellmore, NY) equipped with a water bottle attached to a lick sensor (Mini Mitter, Bend, OR) . Some females were ovariectomized 2 weeks before initiation of activity recording to remove the effect of endogenous estrogens on circadian rhythm. The initial intent of ovariectomy was to allow pooling of data from males and females without confounding effects of estrous cyclicity. Other females and all males remained intact. Lick counts were recorded in 1-min bins using VitalView (Mini Mitter). After entrainment to the 12L:12D schedule, animals were moved into DD for 18 to 21 days and subsequently to LL for 14 days to measure the effect of lighting changes on their circadian period (tau).
For 6-h shift experiments, animals were provided with 4.5-inch diameter activity wheels. Wheel revolutions were recorded upon the circuit closure of hermetically sealed reed switch (Hermetic Switch, Inc., Chickasha, OK), by a neodymium magnet (Magnetic Energies, Inc., San Antonio, TX) attached to each wheel (Tischkau et al., 2003) . After entrainment to a 12L:12D schedule, the light schedule was advanced by 6 h. After 14 days, the cycle was delayed by 6 h. For data analysis, lick and wheel-running counts in 1-min bins were recalculated into 10-min bins by ClockLab (Actimetrics, Evanston, IL). Tau was calculated from activity onset of the last 10 days in DD and LL. Number of days to reentrainment to a new light schedule was estimated by visual analysis of the actograms. Advance shifts were assessed by activity onset; activity offset was used for delay shifts to account for masking by light.
TCDD and Light Exposure
After entrainment in LD, animals were orally dosed with 1 μg/kg BW of TCDD or vehicle (corn oil) during their lights-on period. They were subsequently placed into DD for 8 days; light-pulse experiments were performed to measure phase resetting after light exposure. Each animal was exposed to light (400 lux) for 30 min starting at CT16, as determined by adding a factor of 24/tau to the predicted onset of activity. Tau was calculated from the slope of a regression line drawn through the onset of activity 5 days before the treatment. Light exposure occurred in a separate lit chamber; wheel-running activity data were not collected during the treatment. After 30 min, the cage was returned to DD and collection of activity data was reinitiated. Tau after light treatment was calculated using the activity onset 4 to 8 days after light exposure.
Statistics
Statistical analysis was performed by 1-way ANOVA followed by Tukey's test for pairwise comparisons or by Student's t test using SYSTAT (SSI, Richmond, CA). The p values were 2-sided and considered statistically significant at p < 0.05. All data are shown as mean ± SEM.
RESULTS
Circadian Expression of AhR and Cyp1a1 in SCN and in Liver
To characterize daily expression patterns of AhR and 1 of its signaling target genes, we measured mRNA levels for AhR and Cyp1a1 by real-time RT-PCR. Expression of Per1 and Bmal1 served as positive controls. Figure 1 is double-plotted at CT(ZT)0 and CT(ZT)20 for easier visualization of rhythms. Results show a 24-h oscillation for AhR under both LD and DD, although they were less robust compared with Bmal1 and Per1.
In SCN (Fig.1, left panel) , AhR displayed a peak at ZT12 (2.39 ± 0.2-fold vs. trough expression at ZT0, p < 0.0001) under LD. After 48 h in DD, AhR expression peaked 4 h earlier at CT8 (1.91 ± 0.3-fold vs. trough at CT16, p < 0.01). Levels of Cyp1a1 were weakly rhythmic in the SCN. Peak expression of Cyp1a1 was delayed compared with AhR; levels were highest at ZT20 (1.78 ± 0.1-fold vs. trough at ZT4, p = 0.01) in LD and at CT12 (1.91 ± 0.1-fold vs. trough at CT0, p < 0.01) in DD. Per1 levels peaked at ZT4 (5.00 ± 0.3-fold vs. trough at ZT12, p < 0.0001) in LD and at CT8 (2.31 ± 0.2-fold vs. trough at CT16, p < 0.01) in DD. Bmal1 was characteristically out of phase with Per1, peaking at ZT20 (4.46 ± 0.4-fold vs. trough at ZT12, p < 0.0001) in LD and at CT0 (3.52 ± 0.1-fold vs. trough at CT8, p < 0.0001) in DD.
In liver (Fig. 1, right panel) , AhR peaked at ZT8 (2.02 ± 0.1-fold vs. trough at ZT0, p < 0.0001) under LD, Cyp1a1 peaked at ZT20 (1.87 ± 0.2-fold vs. trough at ZT16, p < 0.001), Per1 peaked at ZT12 (16.95 ± 0.2fold vs. trough at ZT0, p < 0.0001), and Bmal1 peaked at ZT20 (19.32 ± 0.5 fold vs. trough at ZT8, p < 0.0001). Expression patterns were different under DD conditions. Under DD, AhR peaked 8 h earlier at CT0
(2.35 ± 0.04-fold vs. trough at CT12, p < 0.0001). The Cyp1a1 oscillation had a higher amplitude in DD than in LD, with a peak at CT12 (2.58 ± 0.1-fold vs. trough at CT4, p < 0.0001). Per1 had a reduced amplitude compared with LD but still peaked at CT12 (7.46 ± 0.8fold vs. trough at CT4, p < 0.0001) and Bmal1 peaked at CT0 (27.16 ± 0.8-fold vs. trough at CT8, p < 0.0001) under DD.
Circadian Activity Rhythm of AhRKO Mice
There were no apparent abnormalities in the circadian rhythm of AhRKO mice (Fig. 2) . The circadian period of AhRKO males was not significantly different from that of WT males under both DD and LL conditions (Fig.  2G ). Some females were ovariectomized to remove the effect of endogenous estrogens on circadian rhythmicity to pool the data with intact males. However, differences between these 2 groups were observed; therefore, the data are shown separately. Data from intact females were also added as a comparison.
Drinking activity of intact females showed estrous cycledependent changes (Fig. 2B, E) . Changes of activity rhythms caused by estrous cycle have been previously reported in various rodent species (Fitzgerald and Zucker, 1976; Gerall et al., 1973; Morin et al., 1977) . In this study, some mice showed clear estrous cycle-dependent changes (5 of 7 and 4 of 7 in WT and AhRKO, respectively). Of those that showed cyclicity, WT females had a cycle of 3 to 4 days whereas AhRKO had longer cycles of about 5 to 6 days. However, the circadian period under DD and LL was not significantly different between intact WT and AhRKO females (Fig. 2H) .
The only group that showed significant difference (p < 0.05) in circadian period between WT and AhRKO was ovariectomized females (Fig. 2I ). AhRKO mice in this group had shorter tau (23.72 ± 0.03 h) compared with WTs (23.85 ± 0.03 h). Tau under LL was similar (25.35 ± 0.06 and 25.46 ± 0.11 h, WT and AhRKO, respectively). Overall drinking activity appeared to be reduced in ovariectomized (Fig. 2C ) compared with intact females (Fig. 2B) or males ( Fig. 2A) as indicated on the actogram.
Light Entrainment Shifts of AhRKO Mice
To determine whether mice lacking AhR can reentrain to new light conditions, animals were subjected to 6-h advance and delay shifts (Fig. 3) . Wheelrunning activity was used to measure days until reentrainment after 6-h shifts. This change was made because significant drinking during the light phase in the previous study made analysis of activity onset difficult and forced the removal of some samples. We also wanted to determine whether activity differences could be observed using a different behavior. Clear differences between drinking ( Fig. 2A, D) and wheelrunning activity (Fig. 3A) are present in the actograms; however, no significant differences in wheel-running activity were observed between genotypes.
The time needed for mice to entrain to a 6-h advance shift varied from 2 to 10 days. There were no significant differences between WT (6.00 ± 0.75 days) and AhRKO mice (7.09 ± 0.55 days; Fig. 3B ), although 3 of 10 WT reentrained as fast as 2 to 4 days, whereas no AhRKOs (n = 11) reentrained that quickly. Activity offset was used to measure days to reentrainment to delay shifts to avoid the effect of masking by light. There was no significant difference between the genotypes (2.87 ± 0.44 and 2.58 ± 0.42 days; WT and AhRKO, respectively; Fig. 3C ).
Effect of TCDD Exposure on Light-Pulse-Induced Phase Shifts
To study whether exposure to dioxins affects the response to nocturnal light exposure, circadian period and phase shifting was assessed in TCDD-and vehicletreated mice. Rhythms in TCDD-treated mice under DD were as robust as in vehicle-treated mice (Fig. 4A) .
Tau was not altered by TCDD treatment before light exposure (23.70 ± 0.04 and 23.71 ±0.05 h, vehicle-and TCDD-treated) or after light exposure (23.68 ± 0.04 and 23.72 ± 0.04 h, vehicle-and TCDD-treated) (Fig.  4B ). However, the amplitude of phase delay after light exposure was significantly reduced in TCDD-treated (-1.69 ± 0.09 h) compared with vehicle-treated mice (-2.20 ± 0.16 h, p < 0.01; Fig. 4C ).
Per1 and Bmal1 Expression in AhRKO and TCDD-Treated Mice
To determine whether deletion of AhR or TCDD exposure affects clock gene expression, we examined Per1 and Bmal1 levels in SCN and liver of AhRKO and TCDD-treated mice at 2 time points, selected based on relatively high and low levels of expression of these genes under DD as in Figure 1 . Per1 and Bmal1 levels were not changed in the SCN of AhRKO mice, compared with controls at both CT8 and CT20 (Fig. 5A, C) . However, Per1 levels at CT8 were decreased 27% (p < 0.05) in the SCN of TCDD-treated vs. vehicle-treated mice (Fig. 5A) ; TCDD had no effect on Per1 in the SCN at CT20. Bmal1 levels in the SCN were not changed at CT8 with TCDD treatment (Fig. 5C ); at CT20 SCN levels of Bmal1 were increased 21% (p < 0.05) in TCDD-treated mice.
Effects of AhR deletion and TCDD treatment were more prominent in the liver (Fig. 5B, D) . At CT8, levels of Per1 were increased 44% (p < 0.05) in AhRKO vs. WT control, but substantially decreased (51% vs. control, p < 0.01) in TCDD-treated mice (Fig. 5B) . At CT20, Per1 was not changed in AhRKO, but was increased 129% by TCDD exposure. Bmal1 levels were unchanged at CT8, but were increased 52% (p < 0.05) in AhRKO at CT20, compared with control at respective time points (Fig. 5D ). With TCDD treatment, Bmal1 levels were increased 633% (p < 0.001) at CT8, but decreased by 56% (p < 0.05) at CT20.
DISCUSSION
Previous studies indicate that AhR protein expression exhibits a similar oscillatory pattern in the liver, lungs, and thymus of rats (Richardson et al., 1998) , with a peak at approximately ZT5 under LD. AhR mRNA (Huang et al., 2002) expression was also clearly rhythmic in rat liver, although the time of peak relative to the light schedule (14L:10D) was not reported. However, whether expression of AhR or its signaling targets are under control of the endogenous circadian oscillator has remained an open question. Whereas AhR and its dimerization partner ARNT are present in the SCN and other brain regions (Petersen et al., 2000) , circadian variation in the SCN has not, to our knowledge, been reported. Our results demonstrate circadian variation of AhR transcripts in both SCN and liver under LD and DD, although the overall amplitude of oscillation was smaller than the clock genes, Per1 and Bmal1.
Peak mRNA expression of AhR in both SCN and liver under LD occurred at ZT12 and ZT8, respectively. Although apparently contradictory to a previous report (Richardson et al., 1998) , because the protein expression peak in the liver in that report (ZT6) precedes the mRNA expression peak in the current study, differences may simply be related to species, rat versus mouse. Expression of the AhR target gene, Cyp1a1, was out of phase with AhR (4-8 h delay). Under DD, peak expression levels of both AhR and Cyp1a1 were advanced. Whether this reflects shortening of the circadian period under DD conditions, or direct effects of light on expression patterns of these genes, remains to be explored.
Interestingly, the amplitude of Cyp1a1 increased in DD compared with in LD, especially in liver.
Although absolute values could not be compared between LD and DD because the PCR was performed at different times, it is possible that Cyp1a1 expression is increased during the day, resulting in higher basal expression (CT4 under DD). Increased trough expression could result in attenuated amplitude of oscillation. Ultraviolet light exposure upregulates downstream target genes of AhR not only in skin but also in liver (Goerz et al., 1996) , providing a potential mechanism for increased baseline Cyp1a1 expression during the day. Additional experiments that examine AhR signaling in response to light exposure are required to test this hypothesis. Expression patterns of clock genes Per1 and Bmal1 are similar to previous reports (Karman and Tischkau, 2006; Oishi et al., 1998) .
AhRKO mice had no apparent abnormalities in behavioral circadian rhythmicity. Day/night differences in Per1 and Bmal1 transcripts followed the same pattern in AhRKO mice compared with controls. AhRKO mice reentrained to a new light schedule similar to wild-type controls. However, in 6-h advance shift experiments, there was a tendency for AhRKO mice to take longer to adjust to the new light schedule. An increased sample size may produce significant differences between genotypes. The only difference observed was the circadian period between AhRKOs and WTs of ovariectomized females. Although the explanation for this remains obscure, potential interactions between AhR and estrogen receptor (Klinge et al., 2000; Ohtake et al., 2003) may prove to be important. Estrogen replacement in ovariectomized females would help to clarify whether the changes observed are estrogen dependent.
Robust behavioral rhythmicity in AhRKO mice, nevertheless, does not substantiate immediate rejection of the hypothesis that AhR has a role in circadian rhythm. Robust rhythmicity is observed in mice bearing single mutations of known clock genes (Dudley et al., 2003; van der Horst et al., 1999; Zheng et al., 2001) . In fact, deletion of a single clock gene rarely causes complete disruption of rhythmicity (Dudley et al., 2003; van der Horst et al., 1999; Zheng et al., 2001) , with the exception of severe disruption observed in Bmal1 knockouts (Bunger et al., 2000) . Conversely, deletion of 2 clock genes often results in clear behavioral arrythmicity (Bae et al., 2001; Oster et al., 2002; van der Horst et al., 1999) . Robust rhythmicity in Clock null mice (Debruyne et al., 2006) occurs because NPAS2 can functionally substitute for CLOCK (Debruyne et al., 2007) . Similarly, a protein that shares redundancy with AhR may compensate for the complete absence of AhR. Therefore, it would be interesting to study the circadian phenotype of AhR mutant or AhRKO mice that have deletion of another clock gene such as Clock or Npas2.
TCDD affects circadian hormone rhythms (Jones et al., 1987; Pohjanvirta et al., 1989; Yellon et al., 2000) and feeding behaviors (Kelling et al., 1985; Seefeld et al., 1984) . US Vietnam War veterans have sleep disorders that are dependent on TCDD exposure from the defoliant Agent Orange (Liu et al., 2004) . TCDD alters circadian expression of clock genes in murine hematopoietic stem and progenitor cells (Garrett and Gasiewicz, 2006) , in SCN of deer mice (Miller et al., 1999) and C57BL6 mice (Filipski et al., 2004) . Oral TCDD exposure (10 μg/kg BW) has reportedly caused phase advances of behavior rhythm in deer mice (Miller et al., 1999) , as well as behavioral splitting and arrythmicity in mice with a high dose of TCDD .
However, we did not observe these phase advancing or arrhythmic effects in our behavioral studies. C57BL/6J mice exposed to TCDD showed robust rhythmicity in DD for at least 3 weeks following exposure. Transient shifts of wheel-running activity immediately after TCDD exposure were not apparent. Because many previous reports are available only in abstract form Li et al., 2004; Miller et al., 1999) , it is difficult to identify the precise cause of these discrepancies, but differences in TCDD dose and species/strain of animal used may contribute.
TCDD-treated mice showed a small but significant reduction in light-induced phase resetting at CT16. This result is consistent with the inhibition of glutamate-induced phase shifts in brain slices preincubated with the AhR agonist FICZ (Mukai and Tischkau, 2007) . Several factors may contribute to the difference between complete inhibition of the phase shift in vitro and partial inhibition of the phase shift in vivo by AhR agonists. First, it may be due to a reduced ability of TCDD to reach the SCN when administered systemically in vivo (Pohjanvirta et al., 1990) . Although Cyp1a1 induction was observed after incubation of SCN 2.2 with FICZ, this was never observed in SCN in vivo with FICZ administered intraperitoneally (Mukai and Tischkau, 2007) or with TCDD administered by mouth (Mukai M, Tischkau S, unpublished data) . Direct application of AhR agonists onto the SCN or into the third ventricle in vivo could be used to circumvent this problem. Second, the inhibitory effect of an AhR agonist on the phase shift at the level of the SCN firing rate rhythm may not translate efficiently to other mechanisms that could be involved in driving the wheel-running activity rhythm. Altered Per1 and Bmal1 mRNA expression at CT8 and CT20 with TCDD exposure suggests some changes in the clockworks. A phaseresponse curve for light-induced phase shifts in TCDD-treated animals will be necessary to determine whether these animals actually respond less to light overall, or whether their phase response curve is shifted, thus resulting in decreased response at CT16, the time point selected in this study. A phase response curve in AhRKO mice is also planned for future studies.
The mechanism that underlies the attenuation of the light response in TCDD-treated animals requires further investigation. However, immediate metabolism of endogenous ligands by the highly induced xenobiotic metabolic enzymes in certain peripheral tissues may also be important. Moreover, because AhR will be constantly occupied by TCDD, the cyclic pattern of AhR signaling, which is generated physiologically by binding of putative endogenous ligands, such as tryptophan photoproducts, will be disrupted. This may lead to an aberrant light signal.
It is also possible that activation of AhR by TCDD blocks light-induced phase shifts by interfering with induction of Per1 or Per2. Interrelationships between AhR signaling and the Per genes have been demonstrated; TCDD-induced AhR signaling is altered in the mammary glands of Per1 ldc and Per1 ldc /Per2 ldc (Qu et al., 2007) . The physiological significance of these interactions requires further investigation.
Recent discoveries of new PAS domain proteins and their roles in circadian rhythm raise questions regarding whether this ancient family of proteins has evolved as a central mediator of circadian timing among different organisms and tissues. For example, NPAS2, a peripheral replacement for CLOCK in some tissues, is important in the food-entrainable oscillator. Npas2 mouse mutants cannot adapt well to restricted feeding during daylight, leading ultimately to death (Dudley et al., 2003) . AhR is expressed abundantly in various tissues, including the SCN (Petersen et al., 2000) , other parts of the brain, and the rest of the body (Abbott et al., 1995; Carver et al., 1994; Roman and Peterson, 1998) . It is possible that, like Npas2, AhR has evolved to have a specific role in the circadian control of peripheral clocks in a whole organismic system. In this study, both AhR deletion and TCDD exposure had greater effect on Per1 and Bmal1 mRNA expression in the peripheral clock, liver, versus the master clock, SCN. In contrast, to the minimal effect observed in the SCN, the day/night pattern of both Per1 and Bmal1 were strikingly reversed after TCDD treatment in the liver. Determining whether the differences between tissues are due to distribution of TCDD or different responsiveness to TCDD will require further investigation. Although more complete investigation is necessary, it is possible that TCDD exposure caused a phase shift in the molecular clockworks in the liver.
In today's society where people live under schedules that ignore the natural photoperiod provided by sunlight, such as in night-shift workers and international travelers who experience jetlag, the ability to adjust the circadian rhythm is important. Chronic disruption of circadian rhythm manifests as various physiological problems that may lead to more serious diseases, such as sleep and eating disorders and cancer (Haus and Smolensky, 2006) . Xenobiotics that activate AhR are ubiquitous in the environment. Although the AhR-mediated toxicity of TCDD has been studied for decades, mechanisms remain ambiguous. Symptoms associated with dioxin exposure, such as sleep disruption, suggest a relationship with the circadian timing system. Therefore, further investigation on the inhibitory effect of dioxins on light regulation of circadian rhythm is necessary to understand potential novel mechanisms of action of TCDD.
